Rekha Jhunjhunwala Portfolio Stock Gains Rs 14,20,65,000 As Specialty Chemicals Stock Jumps 5%; FII & DII Stake Increases

On Thursday, Indian benchmark indices ended higher, with the Nifty 50 index gaining 0.71 per cent to 24,175.70. Amid the broader market strength, Jubilant Ingrevia closed at Rs 670.80, up 4.68 per cent or Rs 30 from the previous close. The rally increased the value of Ace Investor Rekha Jhunjhunwala's holding by approximately Rs 14.21 crore in a single trading session, based on her holding of 47,35,500 equity shares.

Rekha Jhunjhunwala Continues to Hold Stake

According to the latest March 2026 shareholding pattern, Rekha Jhunjhunwala held a combined 2.97 per cent stake in Jubilant Ingrevia through 47,35,500 equity shares. With the stock gaining Rs 30 during Wednesday's trading session, the value of her holding increased by approximately Rs 14,20,65,000 in a single day. Her shareholding remained unchanged compared with the previous quarter.

FII and DII Shareholding

Foreign Institutional Investors (FIIs) increased their stake to 6.49 per cent in the March 2026 quarter from 6.15 per cent in the December 2025 quarter.

Domestic Institutional Investors (DIIs) also raised their holding to 24.76 per cent from 24.00 per cent during the same period, indicating continued institutional accumulation. Promoter shareholding remained unchanged at 45.22 per cent.
Also Read - Mukul Agrawal Increases Stake In This Low-PE Private Bank; Total Business Grows 20% YoY

Jubilant Ingrevia Share Price Performance

The stock has delivered a 5.22 per cent return over the past one month. However, it declined 7.68 per cent over the last six months and 13.33 per cent over the past one year. Jubilant Ingrevia currently commands a market capitalisation of approximately Rs 10,690 crore.

About Jubilant Ingrevia

Jubilant Ingrevia Ltd is an integrated life science products and specialty chemicals company engaged in the manufacturing of specialty chemicals, nutrition and health ingredients, life science chemicals, and chemical intermediates. The company caters to a diversified customer base across pharmaceuticals, agrochemicals, consumer goods, industrial applications, and nutrition sectors.

The company operates manufacturing facilities across India and exports its products to customers in several international markets. Its diversified product portfolio and integrated manufacturing capabilities enable it to serve both domestic and global industries across multiple end-use segments.

What are your thoughts on Rekha Jhunjhunwala's investment in Jubilant Ingrevia? Share your views in the comments below.
Disclaimer: The article is for informational purposes only and not investment advice.